Search Results for:
Thematic Network. NET-CNS Workshop 4: Innovations in CNS Modeling: Cutting-edge In Vitro Systems
Join us for the fourth NET-CNS Workshop on April 10th! This fourth NET-CNS workshop will focus on innovative experimental platforms and technologies to model central nervous system (CNS) processes and … Read more
Postdoctoral Researcher at the Pluripotency for organ regeneration Research Group
Ref: PD-EG // Deadline: 31/03/2026
Barcelona hosts the fourth edition of the EMBL-IBEC Conference
The fourth EMBL-IBEC Conference, organised by the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL), focused on disease modelling, developmental biology, and regenerative medicine. The event brought around 130 international bioengineering experts together at the PRBB in Barcelona this week.
IBEC Seminar: Dr. Mykhailo Batiuk
Glia, Schizophrenia, and Trauma at Cellular Resolution Dr. Mykhailo Batiuk, École Polytechnique Fédérale de Lausanne. The complexity of the brain in both health and pathology stems from its immense cellular … Read more
Laboratory technician at the nanoprobes and nanoswitches research group
Ref: LT_PG // Deadline: 15/03/2026
Junior Group Leader position in the area of Bioengineering for Personalized Medicine (Ref.: JRGL1)
Ref: JRLG1 // Deadline: 20/03/2026
IBEC welcomes a new international cohort of doctoral students in collaboration with hospitals and centres of excellence
The Institute for Bioengineering of Catalonia (IBEC) is pleased to welcome new international students to its PhD programme. This initiative offers excellent training and research opportunities in bioengineering, as well as strong collaboration with leading hospitals and institutions.
IBEC showcases its leadership in biomedical innovation at MWC26 with three disruptive projects
Last week, Barcelona played host to MWC26, the world’s premier technology and connectivity event. The Institute for Bioengineering of Catalonia was in attendance, showcasing some of its spin-offs and state-of-the-art biomedical technologies, including: Nanobots Therapeutics, Lumiris Spectral Solutions, and Drug4Sight.